Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New Zealand approves Thalidomide for multiple myeloma

Dec. 29, 2003

Target enrollment reached in ASCENT trial of DN-101

Dec. 29, 2003

Exelixis files IND for phase III trial of XL-119

Dec. 29, 2003

Esters of camptothecins with enhanced anticancer activity described in recent patent

Dec. 29, 2003

COX17 as a novel target for NSCLC

Dec. 23, 2003

Mitotic kinesin KSP inhibitors reported by Cytokinetics and GlaxoSmithKline

Dec. 23, 2003

Photobarr PDT recommended for approval in E.U.

Dec. 23, 2003

Array BioPharma and AstraZeneca to develop MEK program for oncology

Dec. 23, 2003

Alexion and XOMA collaborate on c-MPL agonist antibody development

Dec. 23, 2003

Highlights from the 2003 AACR-NCI-EORTC International Conference available on the LifeSci Channel

Dec. 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...